EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

ABS Biotechnologies GmbH

Company (SME/startup) / 中小企業・スタートアップ

www.absbiotechnologies.com/index.phpTulln an der Donau, Austria
48 profile visits

About

ABS Biotechnologies GmbH is an Austrian biotechnology company developing advanced human iPSC-derived cardiovascular cell models for toxicology testing and disease modelling. We provide ethnically diverse human iPSC lines and advanced vascular and cardiac models that enable more predictive, human-relevant preclinical research. Our innovative platforms help pharmaceutical and biotech companies improve drug safety assessment, accelerate drug discovery, and develop more effective therapies for diverse patient populations

Social media

Areas of activity

Business Domain / 分野

Pharmaceuticals / 医薬品Healthcare / ヘルスケア

Business Type / 業種

R&D / 研究開発CRO (Preclinical) / 開発業務受託(非臨床)

Technologies / 技術

Safety evaluation /安全性評価Cell cultivation system and 3D-bioprinter / 細胞培養装置、3Dバイオプリンター

Disease Area / 疾患領域

Cardiovascular /循環器

Additional information

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Companies and Entities (Providing your services or technology to your clients) / 技術・サービス(研究、開発、製造等の提供を目的)

Researched disease area / マッチングご希望の疾患領域

Cardiovascular/ 循環器

Researched Modality / マッチングご希望のモダリティ

Small-molecule drug/低分子医薬Others / その他

Researched Technologies / マッチングご希望の技術

Cell cultivation system and 3D-bioprinter/ 細胞培養装置、3DプリンターOthers /その他